Inter-laboratory variability of A549 epithelial cells grown under submerged and air-liquid interface conditions.
A549 Cells
Cell Culture Techniques
Cell Differentiation
/ drug effects
Cell Proliferation
/ drug effects
Cell Survival
/ drug effects
Epithelial Cells
/ drug effects
Humans
Interleukin-6
/ metabolism
Interleukin-8
/ metabolism
Laboratories
Lipopolysaccharides
/ pharmacology
Reproducibility of Results
Tumor Necrosis Factor-alpha
/ pharmacology
Alveolar epithelial cells
In vitro model
Inter-laboratory assessment
Lung model
Standard operating procedure
Journal
Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
02
12
2020
revised:
26
03
2021
accepted:
22
04
2021
pubmed:
28
4
2021
medline:
8
1
2022
entrez:
27
4
2021
Statut:
ppublish
Résumé
In vitro cell models offer a unique opportunity for conducting toxicology research, and the human lung adenocarcinoma cell line A549 is commonly used for toxicology testing strategies. It is essential to determine whether the response of these cells grown in different laboratories is consistent. In this study, A549 cells were grown under both submerged and air-liquid interface (ALI) conditions following an identical cell seeding protocol in two independent laboratories. The cells were switched to the ALI after four days of submerged growth, and their behaviour was compared to submerged conditions. The membrane integrity, cell viability, morphology, and (pro-)inflammatory response upon positive control stimuli were assessed at days 3, 5, and 7 under submerged conditions and at days 5, 7, and 10 at the ALI. Due to the high variability of the results between the two laboratories, the experiment was subsequently repeated using identical reagents at one specific time point and condition (day 5 at the ALI). Despite some variability, the results were more comparable, proving that the original protocol necessitated improvements. In conclusion, the use of detailed protocols and consumables from the same providers, special training of personnel for cell handling, and endpoint analysis are critical to obtain reproducible results across independent laboratories.
Identifiants
pubmed: 33905840
pii: S0887-2333(21)00103-X
doi: 10.1016/j.tiv.2021.105178
pii:
doi:
Substances chimiques
CXCL8 protein, human
0
IL6 protein, human
0
Interleukin-6
0
Interleukin-8
0
Lipopolysaccharides
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105178Informations de copyright
Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved.